International Stem
Cell Corp., a California-based biotechnology company developing novel stem cell
based therapies and biomedical products, announced today that Executive Vice
President Dr. Simon Craw will present an overview of the company and its
subsidiaries at the BIO 2014 conference on Tuesday, June 24th at 4:15 pm PDT.
The San Diego Convention Center is hosting the conference in the Mission Beach
room. For additional conference details go to: http://convention.bio.org.
Attracting
approximately 15,000 of the most influential biotech and pharma participants
from over 60 countries, BIO is the largest, most influential biotech meeting in
the world. The convention is scheduled to include sessions and specialty forums
covering 17 hot topics, over 1,700 exhibitors and BIO One-on-One Partnering™
meetings with thousands of companies from June 23 – 26th. Those interested in
attending the conference and/or if you would like to schedule a meeting with
ISCO’s management team, please contact the conference organizers. To register
for the event visit the conference website at
http://convention.bio.org/register.
ISCO’s work is
centered on the therapeutic applications of human parthenogenetic stem cells
(hpSCs) and the development and commercialization of cell-based research and
cosmetic products. Parthenogenesis, the company’s core technology, results in
the creation of pluripotent human stem cells from unfertilized oocytes (eggs)
thereby avoiding ethical issues associated with the use or destruction of
viable human embryos. Scientists at the company have created the first
parthenogenetic, homozygous stem cell line that can be a source of therapeutic
cells for hundreds of millions of individuals of differing genders, ages and
racial background with minimal immune rejection after transplantation. The
offerings of hpSCs possess the potential to create the first true stem cell
bank, UniStemCell™. ISCO also produces and markets specialized cells and growth
media for therapeutic research worldwide through its subsidiary Lifeline Cell
Technology and stem cell-based skin care products through its subsidiary
Lifeline Skin Care.
For more information
on the company, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment